Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Shares Outstanding (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Shares Outstanding data on record, last reported at $625.0 in Q2 2025.

  • For Q2 2025, Shares Outstanding fell 85.47% year-over-year to $625.0; the TTM value through Jun 2025 reached $625.0, down 85.47%, while the annual FY2024 figure was $2.1 million, N/A changed from the prior year.
  • Shares Outstanding reached $5.2 million in Q3 2025 per COEP's latest filing, up from $625.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $33.0 million in Q3 2023 and bottomed at $625.0 in Q2 2025.
  • Average Shares Outstanding over 5 years is $4.6 million, with a median of $1.9 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: skyrocketed 261662.95% in 2023, then plummeted 99.98% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $8000.0 in 2021, then changed by 0.0% to $8000.0 in 2022, then soared by 21981.9% to $1.8 million in 2023, then plummeted by 99.63% to $6520.0 in 2024, then crashed by 90.41% to $625.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $625.0 in Q2 2025, $3.4 million in Q1 2025, and $6520.0 in Q4 2024.